Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 276

The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.

Cardiovascular Abnormalities in Sickle Cell Disease

Open access
Gladwin, Mark T., Sachdev, Vandana·2012·Journal of the American College of Cardiology

Abstract

Sickle cell disease is characterized by recurrent episodes of ischemia-reperfusion injury to multiple vital organ systems and a chronic hemolytic anemia, both contributing to progressive organ dysfunction. The introduction of treatments that induce protective fetal hemoglobin and reduce infectious complications has greatly prolonged survival. However, with increased longevity, cardiovascular complications are increasingly evident, with the notable development of a progressive proliferative systemic vasculopathy, pulmonary hypertension (PH) and left ventricular diastolic dysfunction. Pulmonary hypertension is reported in autopsy studies and numerous clinical studies have shown that increased pulmonary pressures are an important risk marker for mortality in these patients. In epidemiological studies, the development of PH is associated with intravascular hemolysis, cutaneous leg ulceration, renal insufficiency, iron overload and liver dysfunction. Chronic anemia in sickle cell disease results in cardiac chamber dilation and a compensatory increase in left ventricular mass. This is often accompanied by left ventricular diastolic dysfunction which has also been a strong independent predictor of mortality patients with sickle cell disease. Both PH and diastolic dysfunction are associated with marked abnormalities in exercise capacity in these patients. Sudden death is an increasingly recognized problem and further cardiac investigations are necessary to recognize and treat high-risk patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2011.10.900

Cites

102 of 102 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 102 references

Research works printed but not linked: 6

  1. Maitre, 2011, Pulmonary complications in adult sickle cell disease, Rev Mal Respir, 28, 129
  2. Brock, 2009, Likelihood of tadalafil-associated adverse events in integrated multiclinical trial database: classification tree analysis in men with erectile dysfunction, Urology, 73, 756, 10.1016/j.urology.2008.10.058 · doi:10.1016/j.urology.2008.10.058
  3. Sachdev, 2011, Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom, Circulation, 124, 1452, 10.1161/CIRCULATIONAHA.111.032920 · DOI · Paper page
  4. Hannoush, 2011, A lower tissue Doppler E/Ea threshold predicts elevated pulmonary capillary wedge pressure in sickle cell patients (abstr), J Am Soc Echocardiogr, 24, B18
  5. Willens, 1983, A noninvasive comparison of left ventricular performance in sickle cell anemia and chronic aortic regurgitation, Clin Cardiol, 6, 542, 10.1002/clc.4960061105 · doi:10.1002/clc.4960061105
  6. Mueller, 2006, Prolonged QT interval in pediatric sickle cell disease, Pediatr Blood Cancer, 47, 831, 10.1002/pbc.20539 · doi:10.1002/pbc.20539

Cited by

See all 276

Metadata

Authors
Gladwin, M. T., & Sachdev, V.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2012-03
Volume
59
Issue
13
Pages
1123-1133
ISSN
0735-1097 (ISSN-L)
OpenAlex
W2033357297
Cited by
276
References
102
FWCI
7.50
Type
journal article
Language
en
Open access
bronze
Licence
Funders
NIH (R01HL098032, RO1HL096973, PO1HL103455)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cardiovascular Abnormalities in Sickle Cell Disease. https://app.cochat.ai/papers/10.1016/j.jacc.2011.10.900
The paper
Gladwin, M. T., & Sachdev, V. (2012). Cardiovascular Abnormalities in Sickle Cell Disease. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2011.10.900

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.